作者
Martin S Tallman, Eunice S Wang, Jessica K Altman, Frederick R Appelbaum, Vijaya Raj Bhatt, Dale Bixby, Steven E Coutre, Marcos De Lima, Amir T Fathi, Melanie Fiorella, James M Foran, Aric C Hall, Meagan Jacoby, Jeffrey Lancet, Thomas W LeBlanc, Gabriel Mannis, Guido Marcucci, Michael G Martin, Alice Mims, Margaret R O’Donnell, Rebecca Olin, Deniz Peker, Alexander Perl, Daniel A Pollyea, Keith Pratz, Thomas Prebet, Farhad Ravandi, Paul J Shami, Richard M Stone, Stephen A Strickland, Matthew Wieduwilt, Kristina M Gregory, Lydia Hammond, Ndiya Ogba
发表日期
2019/6/1
期刊
Journal of the National Comprehensive Cancer Network
卷号
17
期号
6
页码范围
721-749
出版商
National Comprehensive Cancer Network
简介
Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age< 60 years) and older (age≥ 60 years) adult patients.
学术搜索中的文章
MS Tallman, ES Wang, JK Altman, FR Appelbaum… - Journal of the National Comprehensive Cancer …, 2019